Kline Consumer Insight Report
This article was originally published in The Rose Sheet
Executive Summary
Research firm introduces Kline Pulse report "Consumer Insights of Personal Care Innovation 2010," a "ground-breaking" research initiative that gathers authentic consumer insights to help companies make crucial decisions about research and marketing. The first edition of the report offers a glimpse into the nuances of consumer perspectives in personal-care innovation, revealing the underlying attitudes, behaviors, and experiences that drive purchase decisions, Kline says. The scope of the report includes fragrances, hair care, makeup, oral care, skin care and toiletries across various countries. Kline says the approach digs deep into consumer perceptions by avoiding traditional survey techniques such as pre-hypothesizing, categorization or pre-determined definitions so that the data assesses consumers' views "in the context of real experiences." The report also leverages methodologies and software of Cognitive Edge, an organization that uses a science-based approach to organization decision making. The cost of a subscription for the U.S. market is $25,000 and allows unlimited online access to contents via MyKline.com, as well as direct access to the project team
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.